UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
18.39-0.54 (-2.85%)
At close: 04:00PM EDT
18.72 +0.33 (+1.79%)
After hours: 05:29PM EDT

Fresenius Medical Care AG & Co. KGaA

Else-KrOener-Strasse 1
Bad Homburg 61352
Germany
49 6172 609 0
https://www.freseniusmedicalcare.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full-time employees119,845

Key executives

NameTitlePayExercisedYear born
Ms. Helen GizaCEO & Chair of Management Board of Fresenius Med. Care Mgmt AG5.29MN/A1968
Mr. Martin FischerCFO & Member of the Management Board of Fresenius Medical Care Management AG951.43kN/A1977
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG2.97MN/A1957
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG3.09MN/A1963
Mr. Craig Cordola FACHE, M.B.A., M.H.A.CEO of Care Delivery & Member of Management BoardN/AN/A1970
Dr. Dominik HegerExecutive VP and Head of Investor Relations, Strategic Development & CommunicationsN/AN/AN/A
Mr. Joachim WeithSenior Vice President of Corporate Communications & Governmental AffairsN/AN/AN/A
Dr. Gail-Suzanne BrownSenior Vice President of Research & DevelopmentN/AN/AN/A
Mr. Glenn SlaterSenior Vice President of Manufacturing and Supply Chain OperationsN/AN/AN/A
Dr. Wolfgang KummerleSenior Vice President - Quality Management InternationalN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Corporate governance

Fresenius Medical Care AG & Co. KGaA’s ISS governance QualityScore as of 1 April 2024 is 8. The pillar scores are Audit: 3; Board: 7; Shareholder rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.